S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
52-week Low Names To Tip The Upside Scale In Your Favor
The single greatest medical breakthrough of all time? (Ad)
3 Reasons This Sleeping Giant Is About To Wake Up
KB Home Price Weakness is a Signal to Buy this Cash Machine
The single greatest medical breakthrough of all time? (Ad)
Things to know about California's new proposed rules for insurance companies
Analysts Went All In On These Computer Stocks, Save Your Spot
Are "The Magnificent Seven" the Next Sears? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
How major US stock indexes fared Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
52-week Low Names To Tip The Upside Scale In Your Favor
The single greatest medical breakthrough of all time? (Ad)
3 Reasons This Sleeping Giant Is About To Wake Up
KB Home Price Weakness is a Signal to Buy this Cash Machine
The single greatest medical breakthrough of all time? (Ad)
Things to know about California's new proposed rules for insurance companies
Analysts Went All In On These Computer Stocks, Save Your Spot
Are "The Magnificent Seven" the Next Sears? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
How major US stock indexes fared Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
52-week Low Names To Tip The Upside Scale In Your Favor
The single greatest medical breakthrough of all time? (Ad)
3 Reasons This Sleeping Giant Is About To Wake Up
KB Home Price Weakness is a Signal to Buy this Cash Machine
The single greatest medical breakthrough of all time? (Ad)
Things to know about California's new proposed rules for insurance companies
Analysts Went All In On These Computer Stocks, Save Your Spot
Are "The Magnificent Seven" the Next Sears? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
How major US stock indexes fared Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
52-week Low Names To Tip The Upside Scale In Your Favor
The single greatest medical breakthrough of all time? (Ad)
3 Reasons This Sleeping Giant Is About To Wake Up
KB Home Price Weakness is a Signal to Buy this Cash Machine
The single greatest medical breakthrough of all time? (Ad)
Things to know about California's new proposed rules for insurance companies
Analysts Went All In On These Computer Stocks, Save Your Spot
Are "The Magnificent Seven" the Next Sears? (Ad)
MarketBeat Week in Review – 9/18 - 9/22
How major US stock indexes fared Friday, 9/22/2023
NYSE:CLBR

Colombier Acquisition (CLBR) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$8.99
$13.99
52-Week Range
N/A
Volume
16.61 million shs
Average Volume
561,673 shs
Market Capitalization
$299.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CLBR stock logo

About Colombier Acquisition (NYSE:CLBR) Stock

Colombier Acquisition Corp. does not have significant operations. It intends to effectuate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Palm Beach, Florida.


CLBR Stock News Headlines

PSQH - PSQ Holdings, Inc.
AI Creates New Cancer Drug - In Just 30 Days!
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
CLBR - Colombier Acquisition Corp.
AI Creates New Cancer Drug - In Just 30 Days!
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
Colombier Beach
CLBR-WT - Colombier Acquisition Corp. WT
Colombier Acquisition Corp (CLBR)
Colombier Acquisition Corp. Cl A
CLBR Colombier Acquisition Corp.
See More Headlines
Receive CLBR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Colombier Acquisition and its competitors with MarketBeat's FREE daily newsletter.

CLBR Company Calendar

Today
9/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Advertising
Sub-Industry
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Net Income
$5.80 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.27) per share

Miscellaneous

Free Float
N/A
Market Cap
$299.51 million
Optionable
Not Optionable
Beta
0.01
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Omeed Malik J.D. (Age 43)
    Chairman & CEO
  • Mr. Joe Voboril (Age 44)
    CFO & Director













CLBR Stock - Frequently Asked Questions

What is Colombier Acquisition's stock symbol?

Colombier Acquisition trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLBR."

Who are Colombier Acquisition's major shareholders?

Colombier Acquisition's stock is owned by many different institutional and retail investors. Top institutional shareholders include Westchester Capital Management LLC (3.99%), Spartan Fund Management Inc. (0.64%), Shay Capital LLC (0.48%), Tuttle Capital Management LLC (0.14%), Schonfeld Strategic Advisors LLC (0.12%) and Citadel Advisors LLC (0.05%).

How much money does Colombier Acquisition make?

Colombier Acquisition (NYSE:CLBR) has a market capitalization of $0.00.

How many employees does Colombier Acquisition have?

The company employs 2,021 workers across the globe.

How can I contact Colombier Acquisition?

The official website for the company is colombierspac.com. The company can be reached via phone at 561-805-3588 or via email at ir@colombierspac.com.

This page (NYSE:CLBR) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -